Management of novel oral anticoagulants in emergency and trauma surgery

Ana-Catarina Pinho-Gomes1, Adam Hague1, Jonathan Ghosh1

  • 1Department of Vascular Surgery, University Hospital of South Manchester, UK.

Abstract

Insights

Novel oral anticoagulants (NOACs) are increasingly used, posing challenges in emergency surgery. While specific antidotes are emerging, their use will likely be limited, emphasizing supportive care and further research.

Area of Science:

  • Pharmacology
  • Emergency Medicine
  • Surgical Management

Background:

  • Novel oral anticoagulants (NOACs) demonstrate favorable safety and efficacy, leading to expanded therapeutic uses.
  • Managing patients on NOACs during emergency or trauma surgery presents challenges due to the lack of specific reversal agents.
  • This review focuses on management principles for patients on NOACs, highlighting the development of specific antidotes.

Purpose of the Study:

  • To review management strategies for patients on novel oral anticoagulants (NOACs) undergoing emergency or trauma surgery.
  • To emphasize the role and development of specific antidotes for NOACs.
  • To discuss the implications of NOAC use in surgical settings.

Main Methods:

  • Literature review of novel oral anticoagulants (NOACs) and their management in surgical emergencies.
  • Analysis of the development status of specific reversal agents for NOACs.
  • Synthesis of current best practices and emerging evidence.

Main Results:

  • Specific antidotes for NOACs are nearing availability, though their use may be restricted to exceptional cases due to the drugs' short half-lives.
  • NOACs are inherently reversible, suggesting supportive care remains a primary management strategy.
  • Post-marketing surveillance is crucial for understanding the role of new reversal agents.

Conclusions:

  • Management of patients on NOACs in emergency surgery involves supportive care, blood products, and potentially specific antidotes.
  • Familiarity with new reversal agents is essential, but further evidence and guidelines are needed before widespread adoption.
  • Ongoing research and consensus are required to optimize the use of NOAC reversal agents in clinical practice.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
364
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
571
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
633